| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| INTEGRUM Aktie jetzt für 0€ handeln | |||||
| 30.04. | Integrum AB: Integrum implements a write-down of approximately SEK 7 million following reclassification of certain inventory items | 346 | GlobeNewswire (Europe) | Mölndal, Sweden, April 30, 2026 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that, as part of preparing the annual financial statements for the 2025/2026 fiscal year... ► Artikel lesen | |
| 15.04. | Integrum AB: Integrum accelerates Ukraine expansion following landmark decision to expand osseointegration treatment in national healthcare | 206 | GlobeNewswire (Europe) | Mölndal, Sweden, April 15, 2026 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces the appointment of Victoria Boiko to coordinate the company's commercial activities in... ► Artikel lesen | |
| 05.03. | Integrum AB: Integrum publishes Interim Report for the third quarter 2025/26 | 182 | GlobeNewswire (Europe) | Mölndal, 5 March 2026 - Integrum (publ) today publishes its interim report for the third quarter 2025/26. During the quarter, the structural transformation was completed and the company now enters the... ► Artikel lesen | |
| 03.03. | INTEGRUM AB: Integrum invites to presentation of Q3 2025/26 results | 5 | Cision News | ||
| 11.02. | Integrum AB: Integrum optimizes organization to further accelerate commercialization of OPRA Implant System | 442 | GlobeNewswire (Europe) | Mölndal, Sweden, February 11, 2026 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) announces today that the company is implementing organizational changes to accelerate the commercialization... ► Artikel lesen | |
| 02.12.25 | Integrum AB: Integrum's rights issue oversubscribed | 225 | GlobeNewswire (Europe) | Integrum AB (publ) ("Integrum" or the "Company") announced on October 16, 2025 that the Board of Directors had resolved to carry out an issue of shares of series B with preferential right for existing... ► Artikel lesen | |
| 21.11.25 | Integrum AB: Integrum publishes Interim Report for Q2 2025/26 | 215 | GlobeNewswire (Europe) | Second Quarter 2025/26 (August - October)
Net sales amounted to SEK 22.3 (21.8) million.
Operating result totalled SEK -11.1 (-11.3) million.
Profit/loss after tax amounted to SEK -7.4 (-8.9)... ► Artikel lesen | |
| 19.11.25 | True gibt neue Investitionspartnerschaft mit Integrum bekannt, um die Zukunft der Führungskräftevermittlung neu zu definieren | 360 | Business Wire | True, die weltweit führende Plattform für Führungskräfte, die die technologische Entwicklung der Branche durch Daten, KI und Fachwissen vorantreibt, hat heute eine neue strategische Investitionspartnerschaft... ► Artikel lesen | |
| 13.11.25 | Integrum AB: Integrum publishes preliminary financial key figures for the second quarter 2025/26 | 216 | GlobeNewswire (Europe) | Mölndal, 13 November 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B), today publishes, in connection with the ongoing rights issue, preliminary and unaudited financial key figures... ► Artikel lesen | |
| 11.11.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 11.11.2025 | 588 | Xetra Newsboard | Das Instrument TE5 SE0009806045 TERRANET AB B EQUITY wird ex Kapitalmassnahme gehandelt am 11.11.2025 The instrument TE5 SE0009806045 TERRANET AB B EQUITY is traded ex capital adjustment on 11.11.2025Das... ► Artikel lesen | |
| 10.11.25 | Integrum AB: Integrum enters into bridge loan agreement to cover short-term working capital needs | 210 | GlobeNewswire (Europe) | Integrum AB (publ) ("Integrum" or the "Company") has today entered into an agreement for a bridge loan of up to SEK 7 million with Buntel AB. The purpose of the loan is to cover the Company's short-term... ► Artikel lesen | |
| 23.10.25 | Integrum AB: Integrum announces organizational restructuring to strengthen its commercial focus | 300 | GlobeNewswire (Europe) | Mölndal, Sweden, October 23, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announced a strategic organizational restructuring to accelerate the commercialization of OPRA... ► Artikel lesen | |
| 20.10.25 | Integrum AB: Integrum announces that the Swedish Securities Council has published a statement regarding the takeover offer for Integrum | 262 | GlobeNewswire (Europe) | Mölndal, Sweden, October 20, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) notes that, in statement 2025:45 dated October 17, 2025, the Swedish Securities Council (Aktiemarknadsnämnden)... ► Artikel lesen | |
| 16.10.25 | Integrum AB: Integrum resolves on a rights issue of shares of series B of approximately SEK 42.6 million subject to approval by extraordinary general meeting and earlier release of Q2 report | 297 | GlobeNewswire (Europe) | The Board of Directors of Integrum AB (publ) ("Integrum" or the "Company") has today resolved to carry out a share issue of approximately SEK 42.6 million before deduction of issue costs with preferential... ► Artikel lesen | |
| 16.10.25 | Integrum AB: Integrum provides operational update ahead of Q2 report | 215 | GlobeNewswire (Europe) | Mölndal, Sweden, October 16, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today provides an operational update. Following the recent non-completed bid process, Integrum is taking... ► Artikel lesen | |
| 25.09.25 | The observation status for Integrum AB is removed | 296 | GlobeNewswire | On July 22, 2025, the shares in Integrum AB (the "Company") were given observation status with reference to a public takeover offer from OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a... ► Artikel lesen | |
| 01.09.25 | Integrum AB: Stronger positioning paves the way for continued growth | 189 | GlobeNewswire (Europe) | First quarter 2025/26 (May - July)
Net sales amounted to SEK 23.8 (18.5) million.
Operating loss totalled SEK 12.4 (12.0) million.
Profit/loss after tax amounted to SEK -10.0 (-9.4) million.
Earnings... ► Artikel lesen | |
| 22.07.25 | Integrum AB: Statement by the independent bid committee of Integrum AB regarding the public takeover offer from OsteoCentric | 291 | GlobeNewswire (Europe) | The independent bid committee of Integrum AB has decided to recommend that the shareholders of Integrum AB accept OsteoCentric Oncology and Bone Anchored Prostheses, LLC's public takeover offer, based... ► Artikel lesen | |
| 16.06.25 | Integrum AB: Integrum appoints Louise Wåhlin as new Chief Financial Officer | 208 | GlobeNewswire (Europe) | Mölndal, Sweden, June 16th, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that Louise Wåhlin has been appointed new Chief Financial Officer. She will take on... ► Artikel lesen | |
| 03.06.25 | Integrum AB: A rapid shift to full commercial focus | 152 | GlobeNewswire (Europe) | Fourth quarter 2024/25
(February - April)
Net sales amounted to SEK 27.1 m (26.1)
Operating result amounted to SEK -11.7 m (2.6)
Profit/loss after tax amounted to SEK -9.0 m (2.3)
Earnings... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 344,60 | -2,78 % | Intuitive Surgical, Inc.: Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton | SUNNYVALE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the... ► Artikel lesen | |
| MEDTRONIC | 63,08 | -0,82 % | Medtronic im Fokus: Quartalszahlen als Bewährungsprobe im Konzernumbau | ||
| THERMO FISHER | 416,40 | -1,95 % | Laufende Fusionskontrollverfahren: Astorg Group S.à.r.l., Luxemburg; mittelbarer Erwerb alleiniger Kontrolle über den Mikrobiologie-Geschäftsbereich von Thermo Fisher Scientific Inc., Waltham/MA/USA (u.a. Oxoid Deutschland GmbH) | Datum der Anmeldung:22.05.2026Aktenzeichen:B3-68/26Unternehmen:Astorg Group S.à.r.l., Luxemburg; mittelbarer Erwerb alleiniger Kontrolle über den Mikrobiologie-Geschäftsbereich von Thermo Fisher Scientific... ► Artikel lesen | |
| STRATEC | 16,780 | -1,87 % | Stratec-Aktie: Hier zählt die Zukunft | Die Aktie von Stratec befindet sich weiterhin in einer schwierigen Marktphase. Seit dem Hoch im Oktober bei rund 30 € dominiert ein langfristiger Abwärtstrend, der lediglich von zwischenzeitlichen Erholungsbewegungen... ► Artikel lesen | |
| HIMS & HERS HEALTH | 23,760 | -0,42 % | Telemedizin-Aktie legt zu: 1,15-Milliarden-Deal: Hims & Hers expandiert radikal | © Foto: picture alliance / ZUMAPRESS.com | Avishek DasHims & Hers kauft sich mit Eucalyptus in neue Märkte ein - der Milliarden-Deal schürt Fantasie für den nächsten Wachstumsschub.Hims & Hers Health... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 61,32 | -1,00 % | Eurofins Scientific SE: Weekly Report on Share Repurchases From 25th May to 29th May 2026 | Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total... ► Artikel lesen | |
| BECTON DICKINSON | 124,30 | -0,56 % | BD Rowa führt vorausschauendes Wartungskonzept ein: Echtzeitdaten und KI ersetzen feste Serviceintervalle | Kelberg (ots) - Neues datenbasiertes Wartungskonzept maximiert die Verfügbarkeit von Apothekenautomaten, reduziert ungeplante Störungen und ermöglicht Wartung genau dann, wenn sie tatsächlich erforderlich... ► Artikel lesen | |
| FAMICORD | 3,910 | -1,26 % | EQS-News: FamiCord AG verzeichnet erwartungsgemäß schwächeren Start in das Geschäftsjahr 2026 bei anhaltendem Gegenwind aus dem Markt und robuster Abonnementbasis | EQS-News: FamiCord AG
/ Schlagwort(e): Quartalsergebnis
FamiCord AG verzeichnet erwartungsgemäß schwächeren Start in das Geschäftsjahr 2026 bei anhaltendem Gegenwind aus dem Markt... ► Artikel lesen | |
| GERATHERM MEDICAL | 2,710 | -3,21 % | Geratherm Medical wechselt vom Börsensegment Scale in den Open Market | Die Geratherm Medical AG beendet zum 27. April 2026 die Einbeziehung ihrer Aktien in das Börsensegment Scale der Frankfurter Wertpapierbörse und wechselt ins Basic Board am Open Market. Die Börsennotierung... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 40,725 | -1,26 % | Jim Cramer Comments On Boston Scientific and Other Medical Equipment Makers | ||
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB: Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden | EQS-News: SYNLAB
/ Schlagwort(e): Sonstiges
Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden
31.03.2026... ► Artikel lesen | |
| PAUL HARTMANN | 206,00 | -1,44 % | Dividendenbekanntmachungen (30.04.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 4IMPRINT GROUP PLC GB0006640972 1,194 GBP 1,3782 EUR AB DYNAMICS PLC GB00B9GQVG73 0,0308 GBP 0,0355 EUR AGNC INVESTMENT CORP US00123Q1040 0... ► Artikel lesen | |
| RESMED | 157,95 | -1,50 % | Resmed, Inc.: Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio | Acquisition adds Nidra Tonic Motor Activation (TOMAC) Therapy, an FDA De Novo classified, nonpharmacologic treatment designed to address moderate-to-severe Restless Legs Syndrome (RLS).SAN DIEGO, June... ► Artikel lesen | |
| MCKESSON | 627,20 | -0,79 % | Dividendenbekanntmachungen (01.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCOR SA FR0000120404 - 1,35 EUR ACNB CORPORATION US0008681092 0,92 USD 0,7889 EUR AGNICO EAGLE MINES LIMITED CA0084741085 0,45... ► Artikel lesen | |
| BAXTER | 15,650 | -1,11 % | Dividendenbekanntmachungen (29.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGNC INVESTMENT CORP US00123Q1040 0,12 USD 0,1029 EUR AGREE REALTY CORPORATION US0084921008 0,267 USD 0,2291 EUR ALLIED PROPERTIES... ► Artikel lesen |